Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Long-term finasteride use doesn't change bone density or metabolism.

Finasteride doesn't affect hormone levels in normal men.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Hirsutism causes significant psychological distress in women.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

AGA treated with finasteride, minoxidil, and hair transplantation.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride doesn't harm bone density in older men with BPH.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.